CVS Health Corporation (CVS): Price and Financial Metrics
CVS Health Corporation (CVS)
Today's Latest Price: $56.57 USD
Updated Oct 29 8:32am
Add CVS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 4 in Medical - Drug Stores
See all "A" rated Strong Buy stocks
CVS Stock Summary
- CVS has a higher market value than 97.54% of US stocks; more precisely, its current market capitalization is $74,033,354,166.
- CVS HEALTH Corp's stock had its IPO on January 1, 1986, making it an older stock than 92.89% of US equities in our set.
- The volatility of CVS HEALTH Corp's share price is greater than that of merely 1.99% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to CVS HEALTH Corp are ANTM, MDLZ, SHW, TGT, and ITW.
- Visit CVS's SEC page to see the company's official filings. To visit the company's web site, go to www.cvshealth.com.
CVS Stock Price Chart Interactive Chart >
CVS Price/Volume Stats
| Current price | $56.57 | 52-week high | $77.03 |
| Prev. close | $56.57 | 52-week low | $52.04 |
| Day low | $56.57 | Volume | 5,409 |
| Day high | $56.57 | Avg. volume | 8,587,318 |
| 50-day MA | $59.44 | Dividend yield | 3.54% |
| 200-day MA | $62.95 | Market Cap | 74.03B |
CVS Health Corporation (CVS) Company Bio
CVS Health Corporation provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The company was founded in 1892 and is based in Woonsocket, Rhode Island.
CVS Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $56.57 | $253.84 | 349% |
Below please find a table outlining a discounted cash flow forecast for CVS, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that CVS HEALTH Corp ranked in the 74th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 351%. In terms of the factors that were most noteworthy in this DCF analysis for CVS, they are:
- The company has produced more trailing twelve month cash flow than 96.46% of its sector Healthcare.
- 45% of the company's capital comes from equity, which is greater than merely 23.86% of stocks in our cash flow based forecasting set.
- CVS HEALTH Corp's weighted average cost of capital (WACC) is 6%; for context, that number is higher than just 1.43% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 340% |
| 1% | 344% |
| 2% | 349% |
| 3% | 353% |
| 4% | 358% |
| 5% | 362% |
MYL, ABBV, HAE, RDNT, and PRSC can be thought of as valuation peers to CVS, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...